SLC25A1 and cancer: In conclusion, the present study describes the synergistic effect of αKG supplementation in combination with SLC25A1 inhibition on cellular and mitochondrial function, creating a cellular demand for NAD to balance cellular activities important for cancer cell survival and radiosensitization.